Seretra 80 Tablet

Resumen del producto

About Seretra 80 Tablet

Seretra 80 Tablet is a medication containing the active ingredient Seratrodast, classified as Chemical used in the treatment of asthma. Seratrodast (development name, AA-2414; marketed originally as Bronica) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997.

Key Benefits & Uses

• Used for: Seratrodast (development name, AA-2414
• Used for: marketed originally as Bronica) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma
• Used for: It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997

Active Ingredient & Action

Seratrodast, the active ingredient in Seretra 80 Tablet, belongs to the Chemical used in the treatment of asthma class. Its clinical use follows the authorised labelling for Seratrodast-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Seretra 80 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Seretra 80 Tablet for extended periods without medical advice.